Joel Greenblatt's position in Esperion Therapeutics is currently worth $10.7 Thousand. That's 0.00% of their equity portfolio (1348th largest holding). The first Esperion Therapeutics trade was made in Q2 2019. Since then Joel Greenblatt bought shares three more times and sold shares on three occasions. The investor's estimated purchase price is $26.7 Thousand, resulting in a loss of 60%.